中文(繁體)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of Clinical Gastroenterology

Dysbiosis: A Review Highlighting Obesity and Inflammatory Bowel Disease.

只有註冊用戶可以翻譯文章
登陸註冊
鏈接已保存到剪貼板
Adam Kim

關鍵詞

抽象

There are microbes in and on many parts of the human body and all of the microbes that inhabit an ecosystem are the microbiota, which can be commensal, symbiotic, and pathogenic. Alterations in the homeostasis of the microbiota are considered dysbiosis. To determine how changes to the normal flora are associated with disease, we first need to identify normal gut flora. The gold standard for microbiota analysis is currently by 16S rRNA gene amplification techniques. The human diseases, obesity and inflammatory bowel disease, are prime examples of dysbiosis. Both diseases exhibit a decreased diversity of microorganisms and characteristic changes in bacterial phyla as well as evidence of abnormal gut bacterial translocation and inflammation. As standardization of techniques and longitudinal studies come together in multicenter observations of the gut microbiota, a blossoming understanding will inevitably allow us to better diagnose, treat, and possibly even prevent disease.

加入我們的臉書專頁

科學支持的最完整的草藥數據庫

  • 支持55種語言
  • 科學支持的草藥療法
  • 通過圖像識別草藥
  • 交互式GPS地圖-在位置標記草藥(即將推出)
  • 閱讀與您的搜索相關的科學出版物
  • 通過藥效搜索藥草
  • 組織您的興趣並及時了解新聞研究,臨床試驗和專利

輸入症狀或疾病,並閱讀可能有用的草藥,輸入草藥並查看其所針對的疾病和症狀。
*所有信息均基於已發表的科學研究

Google Play badgeApp Store badge